Nyxoah SA (EBR:NYXH)
Belgium · Delayed Price · Currency is EUR 4.100
+0.100 (2.50%)
Last updated: Nov 19, 2025, 9:03 AM CET
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €149.74 million as of November 19, 2025. Its market cap has decreased by -54.28% in one year.
Market Cap
149.74M
Enterprise Value
148.42M
Revenue
5.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.10
Market Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 149.74M, a decrease of -64.16%. That is a compound annual growth rate of -18.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 149.74M | -51.56% |
| Dec 31, 2024 | 309.15M | 153.09% |
| Dec 29, 2023 | 122.15M | -8.05% |
| Dec 30, 2022 | 132.85M | -72.29% |
| Dec 31, 2021 | 479.37M | 37.44% |
| Dec 31, 2020 | 348.77M | -16.52% |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 48.26B |
| UCB SA | 43.32B |
| Financière de Tubize | 8.89B |
| Fagron NV | 1.49B |
| Ion Beam Applications | 295.59M |
| Onward Medical | 185.45M |
| Hyloris Pharmaceuticals | 168.00M |
| Sequana Medical NV | 36.91M |